Key Takeaways
- • Enpam, Italy's €28bn pension fund for doctors, commits an additional €190m to innovative SMEs (€169.4m) and start-ups (€18.7m) as part of its domestic private equity programme, building on over €1bn already deployed in Italian private markets.
- • The fund typically takes a 20% stake in funds investing in innovative companies, with over 30% of its total €1.9bn private markets allocation (approximately €570m+) earmarked for Italian domestic investments.
- • Enpam holds €12.82bn in total Italian investments across its €28bn portfolio as of February 2026, including €3bn in Italian government bonds and approximately €2bn in Italian listed equities, demonstrating strategic commitment to domestic economic growth.
- • The €190m allocation reflects parliamentary pressure on Italian pension funds to demonstrate clearer contributions to domestic economic growth, with Enpam responding through granular allocations to innovative firms rather than broad-based strategies.
- • Historical precedent shows Enpam's venture capital track record: the fund previously invested €150m in an Italian health-sector venture fund that backed a cancer immunotherapy company, which subsequently raised €240m from pharmaceutical sector investors.
Summary
Enpam, the €28bn Italian pension fund for physicians and dentists, has announced a €190m commitment to innovative small and medium-sized enterprises and early-stage start-ups, marking a deliberate shift toward more granular allocations within its private equity programme. The allocation comprises €169.4m directed toward innovative SMEs and €18.7m toward start-ups, according to documentation submitted to the parliamentary committee investigating Italian pension funds' investment strategies.
The decision reflects Enpam's ongoing strategy to increase domestic capital deployment in Italy's private markets ecosystem. Over 30% of the fund's total €1.9bn private markets commitment targets Italian investments, with more than €1bn already deployed and approximately €850m remaining available for future commitments. In 2024 alone, Enpam invested approximately €520m across Italian private equity, private debt, and venture capital programmes. The fund typically assumes a 20% stake in third-party funds investing in innovative companies, providing both capital and governance participation while maintaining portfolio diversification.
Enpam's total exposure to Italian assets stands at €12.82bn out of its €28bn overall portfolio as of February 2026, encompassing €3bn in Italian government bonds, approximately €2bn in Italian listed equities, and substantial private market positions. This substantial domestic allocation demonstrates the pension fund's commitment to supporting Italy's economic growth through institutional capital.
The announcement arrives amid heightened scrutiny from Italian policymakers regarding pension fund investment strategies. Government officials have questioned first-pillar pension funds for professionals and industry-wide schemes on their contributions to domestic economic development, prompting greater transparency regarding allocation decisions. Enpam's enhanced focus on innovative SMEs and start-ups appears positioned as both a response to regulatory oversight and a strategic positioning within Italy's venture capital ecosystem, which has expanded significantly—venture capital investments in Italy grew more than 12-fold between 2017 and 2024, reaching €1.9bn.
Enpam's venture capital experience demonstrates institutional sophistication in the space. The fund previously deployed €150m through an Italian health-sector-focused venture fund backing a company developing cancer immunotherapies, which subsequently secured €240m in follow-on funding from pharmaceutical industry strategic investors. This historical performance underpins confidence in the fund's ability to identify and support high-impact innovation within Italy's domestic economy.
The decision reflects Enpam's ongoing strategy to increase domestic capital deployment in Italy's private markets ecosystem. Over 30% of the fund's total €1.9bn private markets commitment targets Italian investments, with more than €1bn already deployed and approximately €850m remaining available for future commitments. In 2024 alone, Enpam invested approximately €520m across Italian private equity, private debt, and venture capital programmes. The fund typically assumes a 20% stake in third-party funds investing in innovative companies, providing both capital and governance participation while maintaining portfolio diversification.
Enpam's total exposure to Italian assets stands at €12.82bn out of its €28bn overall portfolio as of February 2026, encompassing €3bn in Italian government bonds, approximately €2bn in Italian listed equities, and substantial private market positions. This substantial domestic allocation demonstrates the pension fund's commitment to supporting Italy's economic growth through institutional capital.
The announcement arrives amid heightened scrutiny from Italian policymakers regarding pension fund investment strategies. Government officials have questioned first-pillar pension funds for professionals and industry-wide schemes on their contributions to domestic economic development, prompting greater transparency regarding allocation decisions. Enpam's enhanced focus on innovative SMEs and start-ups appears positioned as both a response to regulatory oversight and a strategic positioning within Italy's venture capital ecosystem, which has expanded significantly—venture capital investments in Italy grew more than 12-fold between 2017 and 2024, reaching €1.9bn.
Enpam's venture capital experience demonstrates institutional sophistication in the space. The fund previously deployed €150m through an Italian health-sector-focused venture fund backing a company developing cancer immunotherapies, which subsequently secured €240m in follow-on funding from pharmaceutical industry strategic investors. This historical performance underpins confidence in the fund's ability to identify and support high-impact innovation within Italy's domestic economy.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.